Wang VS, Kosman J, Yuan H, Lauritsen C, et al. Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study. Headache 2023 Sep 23. doi: 10.1111/head.14636.
PMID: 37740562